Docetaxel, cisplatin and fluorouracil combination in the neoadjuvant treatment of locally advanced gastric adenocarcinoma : Phase II clinical study
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2015
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Fluorouracil (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms Neotax
- Sponsors Sanofi
- 02 Apr 2012 Actual patient number 59 added as reported by ClinicalTrials.gov.
- 02 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.